Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations

被引:0
|
作者
Domenico Delia
Kumiko Goi
Shuki Mizutani
Takayuki Yamada
Antonella Aiello
Enrico Fontanella
Giuseppe Lamorte
Satoshi Iwata
Chikashi Ishioka
Stanislaw Krajewski
John C Reed
Marco A Pierotti
机构
[1] Istituto Nazionale Tumori,Divisione OSA
[2] National Children's Medical Research Center,Department of Virology
[3] Fondazione Matarelli,undefined
[4] Institute of Development,undefined
[5] Aging and Cancer,undefined
[6] Tohoku University,undefined
[7] The Burnham Institute,undefined
[8] Cancer Research Centre,undefined
来源
Oncogene | 1997年 / 14卷
关键词
p53; p21; p34; cell cycle; apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
The radiation response was investigated in two lymphoblastoid cell lines (LBC) derived from families with heterozygous germ-line missense mutations of p53 at codon 282 (LBC282) and 286 (LBC286), and compared to cells with wt/wt p53(LBC-N). By gel retardation assays, we show that p53-containing nuclear extracts from irradiated LBC282 and LBC286 markedly differ in their ability to bind to a p53 DNA consensus sequence, the former generating a shifted band whose intensity is 30 – 40% that of LBC-N, the latter generating an almost undetectable band. Unlike LBC286, which fail to arrest in G1 after irradiation, LBC282 have an apparently normal G1/S checkpoint, as they arrest in G1, like LBC-N. While in LBC-N, accumulation of p53 and transactivation of p21WAF1 increase rapidly and markedly by 3 h after exposure to γ-radiation, in LBC286 there is only a modest accumulation of p53 and a significantly delayed and quantitatively reduced transactivation of p21WAF1. Instead, in LBC282 while p53 levels rise little after irradiation, p21WAF1 levels increase rapidly and significantly as in normal LBC. Apoptotic cells present 48 h after irradiation account for 32% in LBC-N, 8 – 9% in LBC282 and 5 – 7% in LBC286, while the dose of γ-radiation required for killing 50% of cells (LD50) is 400 rads, 1190 rads and 3190 rads, respectively, hence indicating that the heterozygous mutations of p53 at codon 282 affects radioresistance and survival, but not the G1/S cell cycle control. In all LBC tested, radiation-induced apoptosis occurs in all phases of the cell cycle and appears not to directly involve changes in the levels of the apoptosis-associated proteins bcl-2, bax and mcl-1. Both basal as well as radiation-induced p53 and p21WAF1 proteins are detected by Western blotting of FACS-purified G1, S and G2/M fractions from the three cell lines. p34CDC2-Tyr15, the inactive form of p34CDC2 kinase phosphorylated on Tyr15, is found in S and G2/M fractions, but not in G1. However, 24 h after irradiation, its levels in these fractions diminish appreciably in LBC-N but not in the radioresistant LBC286 and LBC282. Concomitantly, p34CDC2 histone H1 kinase activity increases in the former, but not in the latter cell lines, hence suggesting a role for this protein in radiation-induced cell death. Altogether, this study shows that, in cells harbouring heterozygous mutations of p53, the G1 checkpoint is not necessarily disrupted, and this may be related to the endogenous p53 heterocomplexes having lost or not the capacity to bind DNA (and therefore transactivate target genes). Radiation-induced cell death is not cell cycle phase specific, does not involve the regulation of bcl-2, bax or mcl-1, but is associated with changes in the phosphorylation state and activation of p34CDC2 kinase.
引用
收藏
页码:2137 / 2147
页数:10
相关论文
共 50 条
  • [1] Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations
    Delia, D
    Goi, K
    Mizutani, S
    Yamada, T
    Aiello, A
    Fontanella, E
    Lamorte, G
    Iwata, S
    Ishioka, C
    Krajewski, S
    Reed, JC
    Pierotti, MA
    ONCOGENE, 1997, 14 (18) : 2137 - 2147
  • [2] P53 GERMLINE MUTATIONS IN LI-FRAUMENI SYNDROME
    SANTIBANEZKOREF, MF
    BIRCH, JM
    HARTLEY, AL
    JONES, PHM
    CRAFT, AW
    EDEN, T
    CROWTHER, D
    KELSEY, AM
    HARRIS, M
    LANCET, 1991, 338 (8781): : 1490 - 1491
  • [3] LI-FRAUMENI SYNDROME AND P53 GERMLINE MUTATIONS
    LEBLANC, T
    SOUSSI, T
    ARCHIVES DE PEDIATRIE, 1994, 1 (01): : 61 - 70
  • [4] The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
    Li, Yang
    Li, Ting
    Tang, Yuejia
    Zhan, Zhiyan
    Ding, Lixia
    Song, Lili
    Yu, Tingting
    Yang, Yi
    Ma, Jing
    Zhang, Yingwen
    Zhou, Ying
    Gu, Song
    Xu, Min
    Gao, Yijin
    Li, Yanxin
    PLOS ONE, 2020, 15 (06):
  • [5] P53 MUTATIONS IN FAMILIES WITH THE LI-FRAUMENI FAMILY CANCER SYNDROME
    SANTIBANEZKOREF, M
    BIRCH, JM
    HARTLEY, AL
    JONES, PHM
    CRAFT, AW
    EDEN, OB
    CROWTHER, D
    KELSEY, AM
    HARRIS, M
    BLAIR, V
    MITCHELL, EL
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 2107 - 2107
  • [6] Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members
    Lomax, ME
    Barnes, DM
    Hupp, TR
    Picksley, SM
    Camplejohn, RS
    ONCOGENE, 1998, 17 (05) : 643 - 649
  • [7] PREVALENCE AND DIVERSITY OF CONSTITUTIONAL MUTATIONS IN THE P53 GENE AMONG 21 LI-FRAUMENI FAMILIES
    BIRCH, JM
    HARTLEY, AL
    TRICKER, KJ
    PROSSER, J
    CONDIE, A
    KELSEY, AM
    HARRIS, M
    JONES, PHM
    BINCHY, A
    CROWTHER, D
    CRAFT, AW
    EDEN, OB
    EVANS, DGR
    THOMPSON, E
    MANN, JR
    MARTIN, J
    MITCHELL, ELD
    SANTIBANEZKOREF, MF
    CANCER RESEARCH, 1994, 54 (05) : 1298 - 1304
  • [8] Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations
    Liu, PK
    Kraus, E
    Wu, TA
    Strong, LC
    Tainsky, MA
    ONCOGENE, 1996, 12 (11) : 2267 - 2278
  • [9] Li-Fraumeni syndrome, P53 gene, rhabdomyosarcomaRhabdomyosarcoma in a patient with germline TP53 gene mutations: A case report
    Chen, Li-Ping
    Zhang, Wei-Ling
    Huang, Dong-Sheng
    KUWAIT MEDICAL JOURNAL, 2020, 52 (04): : 450 - 454
  • [10] Novel p53 splice site mutations in three families with Li-Fraumeni syndrome
    Sigitas J Verselis
    James G Rheinwald
    Joseph F Fraumeni
    Frederick P Li
    Oncogene, 2000, 19 : 4230 - 4235